{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T13:22:36Z","timestamp":1783084956019,"version":"3.54.6"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12272-1","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T13:04:15Z","timestamp":1783083855000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["ATP5F1B promotes breast cancer progression through ERK associated metabolic reprogramming"],"prefix":"10.1007","volume":"53","author":[{"given":"Xuan","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiejing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiwang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,3]]},"reference":[{"key":"12272_CR1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011276.pub3","volume":"11","author":"G Tosello","year":"2025","unstructured":"Tosello G, Riera R, Torloni MR, Neeman T, Cruz MR, Freitas IF et al (2025) Breast surgery for metastatic breast cancer. Cochrane Database Syst Rev 11:CD011276. https:\/\/doi.org\/10.1002\/14651858.CD011276.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"12272_CR2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2025-111360","volume":"15","author":"G Jassim","year":"2025","unstructured":"Jassim G, Otoom O, Nair B, Hashem J (2025) Performance of artificial intelligence in breast cancer screening programmes: a systematic review. BMJ Open 15:e111360. https:\/\/doi.org\/10.1136\/bmjopen-2025-111360","journal-title":"BMJ Open"},{"key":"12272_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpet.2025.103737","volume":"392","author":"SPL Galappaththi","year":"2025","unstructured":"Galappaththi SPL, Swingle MR (2025) Using nanobodies for breast cancer treatment. J Pharmacol Exp Ther 392:103737. https:\/\/doi.org\/10.1016\/j.jpet.2025.103737","journal-title":"J Pharmacol Exp Ther"},{"key":"12272_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2025.105111","author":"Z Yuan","year":"2026","unstructured":"Yuan Z, Liu Z, Zhou M, Wen H, Li B (2026) Research progress on immunotherapeutics for triple-negative breast cancer from a single-cell perspective. Crit Rev Oncol Hematol. https:\/\/doi.org\/10.1016\/j.critrevonc.2025.105111","journal-title":"Crit Rev Oncol Hematol"},{"key":"12272_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/biom15121688","volume":"15","author":"N Vigo-D\u00edaz","year":"2025","unstructured":"Vigo-D\u00edaz N, L\u00f3pez-Cort\u00e9s R, Velo-Heleno I, Rodr\u00edguez-Silva L, N\u00fa\u00f1ez C (2025) Proteoglycans in breast cancer: friends and foes. Biomolecules 15:1688. https:\/\/doi.org\/10.3390\/biom15121688","journal-title":"Biomolecules"},{"key":"12272_CR6","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.cell.2016.07.002","volume":"166","author":"S Vyas","year":"2016","unstructured":"Vyas S, Zaganjor E, Haigis MC (2016) Mitochondria and cancer. Cell 166:555\u2013566. https:\/\/doi.org\/10.1016\/j.cell.2016.07.002","journal-title":"Cell"},{"key":"12272_CR7","doi-asserted-by":"publisher","first-page":"272","DOI":"10.7150\/thno.121956","volume":"16","author":"D Wang","year":"2026","unstructured":"Wang D, Yuan M, Liu J, Zhao M, Fang T (2026) The application of nanotechnology in regulating mitochondrial function in tumor microenvironment for cancer therapy. Theranostics 16:272\u2013297. https:\/\/doi.org\/10.7150\/thno.121956","journal-title":"Theranostics"},{"key":"12272_CR8","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/cr.2017.155","volume":"28","author":"PE Porporato","year":"2018","unstructured":"Porporato PE, Filigheddu N, Pedro JMB-S, Kroemer G, Galluzzi L (2018) Mitochondrial metabolism and cancer. Cell Res 28:265\u2013280. https:\/\/doi.org\/10.1038\/cr.2017.155","journal-title":"Cell Res"},{"key":"12272_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26146750","volume":"26","author":"AMAM Awad","year":"2025","unstructured":"Awad AMAM, Abdul Karim N (2025) Dysregulation of mitochondrial function in cancer cells. Int J Mol Sci 26:6750. https:\/\/doi.org\/10.3390\/ijms26146750","journal-title":"Int J Mol Sci"},{"key":"12272_CR10","doi-asserted-by":"publisher","first-page":"6097","DOI":"10.1074\/jbc.M111256200","volume":"277","author":"GI Belogrudov","year":"2002","unstructured":"Belogrudov GI, Hatefi Y (2002) Factor B and the mitochondrial ATP synthase complex. J Biol Chem 277:6097\u20136103. https:\/\/doi.org\/10.1074\/jbc.M111256200","journal-title":"J Biol Chem"},{"key":"12272_CR11","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.tranon.2017.06.002","volume":"10","author":"M Br\u00fcggemann","year":"2017","unstructured":"Br\u00fcggemann M, Gromes A, Poss M, Schmidt D, Kl\u00fcmper N, Tolkach Y et al (2017) Systematic analysis of the expression of the mitochondrial ATP synthase (complex V) subunits in clear cell renal cell carcinoma. Transl Oncol 10:661\u2013668. https:\/\/doi.org\/10.1016\/j.tranon.2017.06.002","journal-title":"Transl Oncol"},{"key":"12272_CR12","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1158\/1078-0432.CCR-24-3473","volume":"31","author":"HS Walch","year":"2025","unstructured":"Walch HS, Borpatragohain R, Jee J, Chatila W, Fong C, Maron SB et al (2025) Clinical implications of the cancer genome atlas molecular classification system in esophagogastric cancer. Clin Cancer Res 31:1912\u20131921. https:\/\/doi.org\/10.1158\/1078-0432.CCR-24-3473","journal-title":"Clin Cancer Res"},{"key":"12272_CR13","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.ads6335","volume":"17","author":"Y Ge","year":"2025","unstructured":"Ge Y, Lu J, Puiu D, Revsine M, Salzberg SL (2025) Comprehensive analysis of microbial content in whole-genome sequencing samples from the cancer genome atlas project. Sci Transl Med 17:eads6335. https:\/\/doi.org\/10.1126\/scitranslmed.ads6335","journal-title":"Sci Transl Med"},{"key":"12272_CR14","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.15252\/embr.201744412","volume":"18","author":"C Chinopoulos","year":"2017","unstructured":"Chinopoulos C (2017) ATP synthase complex and the mitochondrial permeability transition pore: poles of attraction. EMBO Rep 18:1041\u20131042. https:\/\/doi.org\/10.15252\/embr.201744412","journal-title":"EMBO Rep"},{"key":"12272_CR15","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1111\/1755-0998.13285","volume":"21","author":"F Mora-M\u00e1rquez","year":"2021","unstructured":"Mora-M\u00e1rquez F, Chano V, V\u00e1zquez-Poletti JL, L\u00f3pez de Heredia U (2021) TOA: a software package for automated functional annotation in non-model plant species. Mol Ecol Resour 21:621\u2013636. https:\/\/doi.org\/10.1111\/1755-0998.13285","journal-title":"Mol Ecol Resour"},{"key":"12272_CR16","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1007\/s12011-023-04017-z","volume":"202","author":"V Mattos Pereira","year":"2024","unstructured":"Mattos Pereira V, Nair S (2024) Targeting mitochondrial ATP-synthase: evolving role of chromium as a regulator of carbohydrate and fat metabolism. Biol Trace Elem Res 202:1318\u20131324. https:\/\/doi.org\/10.1007\/s12011-023-04017-z","journal-title":"Biol Trace Elem Res"},{"key":"12272_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s10020-025-01378-0","volume":"31","author":"V Del Dotto","year":"2025","unstructured":"Del Dotto V, Grillini S, Righetti R, Grandi M, Giorgio V, Solaini G et al (2025) Bioenergetics of cancer cells: insights into the warburg effect and regulation of ATP synthase. Mol Med 31:311. https:\/\/doi.org\/10.1186\/s10020-025-01378-0","journal-title":"Mol Med"},{"key":"12272_CR18","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.2174\/0113895575254320231030051124","volume":"24","author":"DX Robledo-Cadena","year":"2024","unstructured":"Robledo-Cadena DX, Pacheco-Velazquez SC, Vargas-Navarro JL, Padilla-Flores JA, Moreno-Sanchez R, Rodr\u00edguez-Enr\u00edquez S (2024) Mitochondrial proteins as metabolic biomarkers and sites for therapeutic intervention in primary and metastatic cancers. Mini Rev Med Chem 24:1187\u20131202. https:\/\/doi.org\/10.2174\/0113895575254320231030051124","journal-title":"Mini Rev Med Chem"},{"key":"12272_CR19","first-page":"6674","volume":"62","author":"JM Cuezva","year":"2002","unstructured":"Cuezva JM, Krajewska M, de Heredia ML, Krajewski S, Santamar\u00eda G, Kim H et al (2002) The bioenergetic signature of cancer: a marker of tumor progression. Cancer Res 62:6674\u20136681","journal-title":"Cancer Res"},{"key":"12272_CR20","doi-asserted-by":"publisher","first-page":"10426","DOI":"10.1038\/s41467-025-66460-x","volume":"16","author":"SB Lee","year":"2025","unstructured":"Lee SB, Thanh Thu B, Nam TW, Song Y, Lee JH, Jeong Y et al (2025) Ei24 deficiency in brown adipocytes induces severe hypothermia under cold stress independent of UCP1 activity. Nat Commun 16:10426. https:\/\/doi.org\/10.1038\/s41467-025-66460-x","journal-title":"Nat Commun"},{"key":"12272_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05572-y","volume":"14","author":"C Galber","year":"2023","unstructured":"Galber C, Fabbian S, Gatto C, Grandi M, Carissimi S, Acosta MJ et al (2023) The mitochondrial inhibitor IF1 binds to the ATP synthase OSCP subunit and protects cancer cells from apoptosis. Cell Death Dis 14:54. https:\/\/doi.org\/10.1038\/s41419-023-05572-y","journal-title":"Cell Death Dis"},{"key":"12272_CR22","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.bbrc.2022.09.084","volume":"632","author":"H-A Park","year":"2022","unstructured":"Park H-A, Brown SR, Jansen J, Dunn T, Scott M, Mnatsakanyan N et al (2022) Fluid shear stress enhances proliferation of breast cancer cells via downregulation of the c-subunit of the F1FO ATP synthase. Biochem Biophys Res Commun 632:173\u2013180. https:\/\/doi.org\/10.1016\/j.bbrc.2022.09.084","journal-title":"Biochem Biophys Res Commun"},{"key":"12272_CR23","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202357339","volume":"24","author":"S Liu","year":"2023","unstructured":"Liu S, Benito-Martin A, Pelissier Vatter FA, Hanif SZ, Liu C, Bhardwaj P et al (2023) Breast adipose tissue-derived extracellular vesicles from obese women alter tumor cell metabolism. EMBO Rep 24:EMBR202357339. https:\/\/doi.org\/10.15252\/embr.202357339","journal-title":"EMBO Rep"},{"key":"12272_CR24","doi-asserted-by":"publisher","first-page":"4434466","DOI":"10.1155\/2024\/4434466","volume":"2024","author":"S Miao","year":"2024","unstructured":"Miao S, Ni Q, Fang J (2024) Relationship between mitochondrial biological function and breast cancer: an approach based on mendelian randomization analysis. Breast J 2024:4434466. https:\/\/doi.org\/10.1155\/2024\/4434466","journal-title":"Breast J"},{"key":"12272_CR25","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s12276-022-00735-x","volume":"54","author":"N Zhang","year":"2022","unstructured":"Zhang N, Shen Y, Li H, Chen Y, Zhang P, Lou S et al (2022) The m6A reader IGF2BP3 promotes acute myeloid leukemia progression by enhancing RCC2 stability. Exp Mol Med 54:194\u2013205. https:\/\/doi.org\/10.1038\/s12276-022-00735-x","journal-title":"Exp Mol Med"},{"key":"12272_CR26","doi-asserted-by":"publisher","first-page":"3162","DOI":"10.1158\/0008-5472.CAN-04-3300","volume":"65","author":"Y-K Shin","year":"2005","unstructured":"Shin Y-K, Yoo BC, Chang HJ, Jeon E, Hong S-H, Jung M-S et al (2005) Down-regulation of mitochondrial F1F0-ATP synthase in human colon cancer cells with induced 5-fluorouracil resistance. Cancer Res 65:3162\u20133170. https:\/\/doi.org\/10.1158\/0008-5472.CAN-04-3300","journal-title":"Cancer Res"},{"key":"12272_CR27","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1038\/s41388-018-0582-8","volume":"38","author":"S Papa","year":"2019","unstructured":"Papa S, Choy PM, Bubici C (2019) The ERK and JNK pathways in the regulation of metabolic reprogramming. Oncogene 38:2223\u20132240. https:\/\/doi.org\/10.1038\/s41388-018-0582-8","journal-title":"Oncogene"},{"key":"12272_CR28","doi-asserted-by":"publisher","first-page":"S26","DOI":"10.1016\/j.breast.2015.07.008","volume":"24","author":"A Prat","year":"2015","unstructured":"Prat A, Pineda E, Adamo B, Galv\u00e1n P, Fern\u00e1ndez A, Gaba L et al (2015) Clinical implications of the intrinsic molecular subtypes of breast cancer. Breast 24:S26-35. https:\/\/doi.org\/10.1016\/j.breast.2015.07.008","journal-title":"Breast"},{"key":"12272_CR29","doi-asserted-by":"publisher","DOI":"10.1080\/17437199.2025.2592667","author":"M Boberska","year":"2025","unstructured":"Boberska M, Wietrzykowska D, Kulis E, Kuzminska J, Zalewska-Lunkiewicz K, Karaglani E et al (2025) Behaviour change techniques used in effective interventions, promoting physical activity, healthy nutrition, and healthy body mass among women with breast cancer and breast cancer survivors: a meta-review. Health Psychol Rev. https:\/\/doi.org\/10.1080\/17437199.2025.2592667","journal-title":"Health Psychol Rev"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12272-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12272-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12272-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T13:04:16Z","timestamp":1783083856000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12272-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,3]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12272"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12272-1","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,3]]},"assertion":[{"value":"6 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted using publicly available, de-identified transcriptomic and clinical datasets, and no new human participants or identifiable personal data were involved. Ethical approval for this study was granted by the Ethics Committee of The Affiliated Hospital of Yangzhou University (Approval number: 2025110408). Informed consent was not required in accordance with institutional and national research guidelines. All cell line experiments were performed in compliance with relevant institutional biosafety regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no conflicts of interest in this work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"1096"}}